Literature DB >> 33991004

The preoperative C-reactive protein-lymphocyte ratio and the prognosis of oral cavity squamous cell carcinoma.

Chien-An Ko1, Ku-Hao Fang2, Cheng-Ming Hsu1, Yi-Chan Lee3, Geng-He Chang1, Ethan I Huang1, Ming-Shao Tsai1, Yao-Te Tsai1.   

Abstract

BACKGROUND: We aimed to investigate the preoperative C-reactive protein (CRP)-lymphocyte ratio (CLR) as a prognostic biomarker in oral cavity squamous cell carcinoma (OSCC).
METHODS: Three hundred and sixteen patients with OSCC treated with curative surgery were retrospectively assessed and the receiver operating characteristic curve was used to evaluate the discriminative ability of inflammatory markers. The prognostic value of CLR was investigated with Cox proportional hazards analysis.
RESULTS: The CLR cutoff of 3.88 (p < 0.001) demonstrated optimal prognostic performance compared with other inflammatory combinations. A higher preoperative CLR (≥3.88) was significantly associated with clinicopathological aggressiveness and predicted unfavorable overall survival and disease-free survival (hazard ratios = 3.498 and 1.994, respectively; both p < 0.001). The CLR-based nomogram provided accurate survival prediction (concordance index: 0.803).
CONCLUSIONS: Preoperative CLR is a feasible prognostic biomarker in patients with OSCC, and the CLR-based nomogram might serve as prognostic tool in era of personalized medicine.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  C-reactive protein-lymphocyte ratio; biomarker; nomogram; oral cavity cancer; prognosis

Year:  2021        PMID: 33991004     DOI: 10.1002/hed.26738

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  4 in total

1.  C-reactive protein to lymphocyte count ratio is a promising novel marker in hepatitis C infection: the clear hep-c study.

Authors:  Muhammed Emin Demirkol; Gulali Aktas; Satilmiş Bilgin; Gizem Kahveci; Ozge Kurtkulagi; Burcin Meryem Atak; Tuba Taslamacioglu Duman
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-06-24       Impact factor: 1.712

2.  Prognostic Impact of Serum CRP Level in Head and Neck Squamous Cell Carcinoma.

Authors:  Yaoting Zhang; Dongsheng Gu
Journal:  Front Oncol       Date:  2022-06-29       Impact factor: 5.738

3.  Therapeutic Perspectives for the Perioperative Period in Oral Squamous Cell Carcinoma (OSCC).

Authors:  Antoine Galmiche; Zuzana Saidak; Jérémie Bettoni; Martial Ouendo; Sylvie Testelin
Journal:  Front Oral Health       Date:  2022-01-11

4.  Prognostic Value of CRP-Albumin-Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Oral Cavity Cancer.

Authors:  Yao-Te Tsai; Chien-An Ko; Hung-Chin Chen; Cheng-Ming Hsu; Chia-Hsuan Lai; Yi-Chan Lee; Ming-Shao Tsai; Geng-He Chang; Ethan I Huang; Ku-Hao Fang
Journal:  J Cancer       Date:  2022-07-27       Impact factor: 4.478

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.